Skip to main content

Condition · 1 treatment path

Cholangiocarcinoma

Cholangiocarcinoma is cancer of the bile ducts, arising inside the liver, at the junction where the ducts leave the liver, or in the lower duct near the pancreas. It is uncommon and often found late.

Severe

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Last updated: How we source & review

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
1Treatment paths
Specialties
1Specialties
Typical severity
SevereTypical severity

About cholangiocarcinoma

What to know

Typical features are painless jaundice with dark urine and pale stools, itching, weight loss and abdominal discomfort. Diagnosis combines blood tests, CT or MRI with MRCP imaging, endoscopic or percutaneous assessment of the duct and biopsy. Because it grows quietly along the ducts, many cases are advanced at diagnosis, and outlook depends mainly on whether the tumour can be removed.

Surgical removal is the only potentially curative treatment and, for tumours in or near the liver, often means a liver resection, sometimes with bile duct reconstruction. Many people cannot have surgery, and receive chemotherapy, stenting to relieve jaundice and sometimes other targeted treatments. Treatment abroad is typically considered to obtain a specialist opinion on whether the tumour is resectable.

Pre-flight workup

Tests to have already done

  • Contrast CT or MRI with MRCP of the liver and bile ducts, with the images on disc, to show the tumour's position and relation to vessels.
  • Biopsy or brush cytology report, where obtained, and CA 19-9 and liver function blood tests.
  • Chest CT and any PET-CT to look for spread to the lungs, lymph nodes or elsewhere.
  • Records of any bile duct drainage procedure, stent or ERCP, with dates and results.
  • Hepatitis B and C status, ultrasound or elastography showing liver quality, and a list of current medicines.

Second opinion

When to get a second look

  • You were told the tumour is inoperable, and no liver or hepatobiliary surgery centre has reviewed the scans.
  • Your tumour location is in the hilum or inside the liver and the type of resection offered seems unclear.
  • You are offered chemotherapy only, and want to know whether the tumour could be made removable.

Talking to your doctor

Questions to ask

  1. Is this intrahepatic, perihilar or distal bile duct cancer, and how does that change the plan?
  2. Can the tumour be fully removed, and will enough healthy liver remain afterwards?
  3. Do I need a procedure to relieve jaundice or to grow the remaining liver before surgery?
  4. Would chemotherapy before or after surgery help in my case?
  5. What scans and blood tests will follow, and how often, to detect recurrence?

Outlook

Realistic prognosis

Outlook depends mainly on whether the tumour can be completely removed and whether lymph nodes are involved. After complete resection some patients live for years, but recurrence is common, so follow-up and often chemotherapy are important. If the cancer cannot be removed or has spread, treatment aims to control disease and symptoms, and survival is considerably shorter.

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For cholangiocarcinoma, plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.

  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.

  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.

  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

04 · FAQ

Common questions about cholangiocarcinoma

Is cholangiocarcinoma always inoperable?

No. A minority of tumours found early can be removed completely, which offers the best chance of cure. Whether surgery is possible depends on location, spread, vessel involvement and what volume of healthy liver would remain.

Can it come back after surgery?

Yes, recurrence is relatively common, even after complete removal, which is why chemotherapy after surgery is often advised and why scans and blood tests continue for years.

Can I travel while having jaundice?

Jaundice or a blocked duct should be treated first, usually by drainage with a stent, because infection of the bile can be serious. Your team will advise when travel is safe.

Clinical context

Working up cholangiocarcinoma properly

A condition like cholangiocarcinoma is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
How this page is made

Methodology and editorial standards

This cholangiocarcinoma overview is written by the editorial team from published Oncology sources and lists 1 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
  2. Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
  3. Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
  4. Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
  5. Independence. Hospitals cannot pay to change their position on our pages.
Data sources for this page
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Next step · Cholangiocarcinoma

Free second opinion on your Cholangiocarcinoma case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.